Stories about Medizin, Gesundheit

Sysmex Inostics GmbH

Sysmex Inostics' updated SafeSEQ Breast Cancer Panel advances novel clinical uses of ctDNA through quantitative testing

Baltimore, Maryland (ots) - Building on the ultra-high sensitivity SafeSEQ Breast Cancer Panel circulating tumor DNA (ctDNA) test launched at the American Association of Cancer Research 2019 annual meeting, Sysmex Inostics has updated the test to provide additional key information for investigation of the validity ...

EUROEXPO Messe- und Kongress GmbH

2

LogiMAT 2020 Canceled

EUROEXPO Messe- und Kongress GmbH

2

LogiMAT 2020 Going Forward as Planned

Fördergesellschaft IZB mbH

Inspirational talks form SIRION Biotech, CLS Behring and the German Accelerator at the 13th Biotech Press Lounge at the IZB

Technische Universität München

Active droplets: Long-lasting and precise dosing of medication thanks to an oil-hydrogel mixture

TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 89 289 10510 - e-mail: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/details/35918/ High resolution images: https://mediatum.ub.tum.de/1538709 NEWS RELEASE Active droplets Long-lasting and precise dosing of medication thanks to an ...

DERMALOG Identification Systems GmbH

DERMALOG provides the world's first biometric border control system with integrated fever detection (FOTO)

Technische Universität München

Major project for Munich neurosciences

TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 8161 71 5403 - email: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/details/35908/ High resolution images: https://mediatum.ub.tum.de/1537625 NEWS RELEASE CLINSPECT-M: Clinical mass spectrometry center for molecular brain research Major project for Munich neurosciences In a joint ...

Spectrum. The most dangerous artwork

On February 4 is World Cancer Day. German Cancer Aid and Dermatological Prevention Association demand: Sunbed Ban

Sysmex Inostics GmbH

Sysmex Inostics and Oxford Gene Technology plasma and tissue sequencing show clearance of ctDNA correlates with pathologic complete response in breast cancer patients during neoadjuvant treatment

Hamburg, Germany and Baltimore, Maryland (ots) - Pathologist Dr. Vincente Peg of the Vall d´Hebron University Hospital (Barcelona Spain) and colleagues have presented a correlation between the clearance of circulating tumor DNA (ctDNA) in HER2-positive or triple-negative breast cancer patients undergoing ...

Technische Universität München

Gene scissors for Duchenne muscular dystrophy

TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 89 289 22562 - email: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/details/35877/ NEWS RELEASE Gene scissors against incurable muscular disease New gene correction therapy for Duchenne muscular dystrophy Duchenne type muscular dystrophy (DMD) is the most common hereditary muscular ...

Spectrum. The most dangerous artwork

The World's Most Dangerous Artwork / Cancer charity Deutsche Krebshilfe (German Cancer Aid), ADP, and the artistic duo LOW BROS welcomed guests to a somewhat unusual gallery opening

Technische Universität München

Gene network helps to turn white fat into beneficial calorie burning fat

TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 89 289 22798 - email: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/en/about-tum/news/ High resolution images: https://mediatum.ub.tum.de/1524726 NEWS RELEASE A new approach to treating overweight and obesity Gene network helps to turn white fat into beneficial calorie ...

Technische Universität München

From cancer medication to antibiotic: modified cancer drug effective against multi-resistant bacteria

TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 89 289 10510 - e-mail: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/details/35822/ High resolution images: https://mediatum.ub.tum.de/1524870 NEWS RELEASE From cancer medication ...

Cilian AG

New in-vivo study confirms that ciliate vaccine protects against flu

Sysmex Inostics GmbH

Sysmex Inostics announces first results of tissue-independent liquid biopsy for early stage breast cancer mutation characterization and monitoring using ultra-sensitive SafeSEQ technology

Hamburg, Germany and Baltimore, Maryland (ots) - New data presented by Dr. Ben Ho Park, Professor of Medicine and Director of Precision Oncology at Vanderbilt University and colleagues at the recent San Antonio Breast Cancer Symposium (SABCS) in San Antonio, Texas demonstrated a potential utility for monitoring ...

Hitachi Medical Systems Europe Holding AG

2

Hitachi and Centre Léon Bérard cancer center in Lyon to launch a research collaboration in the fight against cancer with AI

Global Health Centre, The Graduate Institute of International and Development Studies

The Lancet and Financial Times partner for first joint Commission on Governing health futures 2030: Growing up in a digital world

Fördergesellschaft IZB mbH

The development of a combination drug for immunotherapy and trends of the VC and pharmaceutical branch were introduced at the IZB

Versameb AG

Versameb raises CHF 6.4 million in Seed C round and strengthens the team

Basel (ots) - Versameb AG, a Swiss biopharmaceutical company, announced today the successful closing of a CHF 6.4 million Seed C financing round, bringing the total capital raised to date to CHF 11.8 million. Versameb is focusing on the discovery and development of innovative, next-generation RNA-based drugs. The proceeds of this financing round will be used to expand ...

Universität Mannheim

Six Components of Healthy Family Meals

Six Components of Healthy Family Meals Meta-analysis of data from over 29,000 respondents worldwide Turning the TV off, taking time to eat, not arguing at the table: Researchers from the Max Planck Institute for Human Development and the University of Mannheim have evaluated studies examining the quality of family meals. Their findings can serve as guidelines for parents and guardians wanting to help their children ...

Technische Universität München

Weak spot in pathogenic bacteria: ClpX-ClpP protein complex could be starting point for new antibiotics

TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 89 289 10510 - e-mail: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/details/35720/ High resolution images: https://mediatum.ub.tum.de/1520810 NEWS RELEASE Weak spot in pathogenic bacteria ClpX-ClpP protein complex could be starting ...

Sysmex Inostics GmbH

Sysmex Inostics launches two NGS-based liquid biopsy panels for cancer therapy drug development

Hamburg, Germany and Baltimore, Maryland (ots) - Sysmex Inostics announces the availability of the SafeSEQ Breast Cancer and Head and Neck Cancer Panels along with the SafeSEQ Rapid Custom Development program for circulating tumor DNA (ctDNA) analysis. SafeSEQ is a next-generation sequencing (NGS)-based approach that delivers sensitivity comparable to the clinically ...

Brenntag SE

Brenntag Food & Nutrition signs agreement with Axiom Foods for EMEA

Dear all, Please find attached the press release of Brenntag Food & Nutrition regarding the agreement with Axiom Foods for the distribution of its plant-based products in EMEA, excluding UK & Ireland. For further information please see the press release. Please do not hesitate to ...

Sysmex Inostics GmbH

Sysmex Inostics publishes first feasibility study of NGS-based liquid biopsy to complement early breast cancer screening by imaging

Hamburg/Baltimore (ots) - Using Sysmex Inostics' novel SafeSEQ next-generation sequencing cell-free DNA technology, investigators from the Biomedical Research Institute of Malaga [(IBIMA)-CIMES-UMA, Malaga Spain] and collaborators have published the first pilot study to examine the use of a non-invasive liquid ...